Pharma Journalist 8916 posts 0 comments

Alligator Bioscience announced that the company has entered into a research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based in Finland,…
Read More...

NRx Pharmaceuticals (NRx) a clinical stage, biopharmaceutical company provided a safety update on ZYESAMI (aviptadil) which is being tested in the ACTIV-3 Critical Care Phase 3 study…
Read More...

Roche announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that…
Read More...

Jardiance (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults…
Read More...

CM Life Sciences II and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering…
Read More...

SMi Group reports: 4th Annual Ophthalmic Drugs Conference taking place on the 22nd-23rd of November 2021, in London With 50% of the global population predicted to have complications…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the…
Read More...

GlaxoSmithKline (GSK) plc announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly), a programmed cell death receptor-1 (PD-1)…
Read More...

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionary COVID-19…
Read More...

Gritstone bio, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding…
Read More...